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Abstract
Background: Women with a history of pre-eclampsia have a higher risk of developing pre-eclampsia in subsequent
pregnancies. However, the role of the inter-pregnancy interval on this association is unclear.
Objective: To explore the effect of inter-pregnancy interval on the risk of recurrent pre-eclampsia or eclampia.
Search strategy: MEDLINE, EMBASE and LILACS were searched (inception to July 2015).
Selection criteria: Cohort studies assessing the risk of recurrent pre-eclampsia in the immediate subsequent
pregnancy according to different birth intervals.
Data collection and analysis: Two reviewers independently performed screening, data extraction, methodological
and quality assessment.
Meta-analysis of adjusted odds ratios (aOR) with 95 % confidence intervals (CI) was used to measure the association
between various interval lengths and recurrent pre-eclampsia or eclampsia.
Main results: We identified 1769 articles and finally included four studies with a total of 77,561 women. The meta-analysis
of two studies showed that compared to inter-pregnancy intervals of 2–4 years, the aOR for recurrent pre-eclampsia was 1.
01 [95 % CI 0.95 to 1.07, I2 0 %] with intervals of less than 2 years and 1.10 [95 % CI 1.02 to 1.19, I2 0 %] with intervals longer
than 4 years.
Conclusion: Compared to inter-pregnancy intervals of 2 to 4 years, shorter intervals are not associated with an increased
risk of recurrent pre-eclampsia but longer intervals appear to increase the risk. The results of this review should be
interpreted with caution as included studies are observational and thus subject to possible confounding factors.
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Birth spacing, Hypertensive disorders of pregnancy
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Background
Pre-eclampsia is a gestational disorder usually defined as
hypertension accompanied by proteinuria [1]. It remains
a major cause of maternal and neonatal mortality and
morbidity worldwide [2]. Pre-eclampsia can lead to
severe complications such as eclampsia, liver rupture,
stroke, renal failure, or eodema in the mother and fetal
growth restriction and pre-term birth in the newborn. A
recent revised definition proposes proteinuria not to be
required for the diagnosis of pre-eclampsia as long as
there is a persistant high blood pressure associated with
one or more severe complications or adverse conditions
[1, 3]. Women with a history of pre-eclampsia have a
higher risk of developing pre-eclampsia in subsequent
pregnancies [4–6]. This risk of recurrent pre-eclampsia
varies from 7 to 65 % depending on factors such as gesta-
tional age at the onset or delivery of the initial pregnancy,
severity of the disease and women’s pre-existing medical
disorders [6].
The relationship between birth interval and maternal and
perinatal outcomes has been studied extensively [7, 8].
Short inter-pregnancy intervals (< 18 months) may be asso-
ciated with adverse pregnancy outcomes due to depletion
of maternal nutrients and to the failure to treat existing co-
morbidities [9, 10]. Whereas longer inter-pregnancy inter-
vals might allow more complete recovery of the mother,
they are associated with reduced fertility, older age, mater-
nal disorders and partner change that are also linked with
higher risk of pre-eclampsia [11]. A recent analysis of
894,476 women with consecutive pregnancies in 18 Latin
American countries showed that longer birth intervals had
increased odds of pre-eclampsia [8].
However, for those women who develop pre-eclampsia,
it is not clear whether the inter-pregnancy interval is asso-
ciated with the risk of recurrent pre-eclampsia in the
following pregnancy. A Norwegian study of 19,970 women
with pre-eclampsia found that the risk of having recurent
pre-eclampsia in the following pregnancy tended to
decrease with increasing time interval between deliveries,
although the results were not significant [12]. Two other
studies found no difference in the recurrence of pre-
eclampsia according to inter-pregnancy interval [13, 14].
In 2010 the National Institute for Health Care Excel-
lence (NICE) Clinical guidelines for the management of
hypertensive disorders during pregnancy reported that
there is no increased risk of recurrent pre-eclampsia with
inter-pregnancy intervals up to 10 years, but the level of
evidence was derived from a single well-conducted cohort
study, with low risk of bias [15]. In their 2014 update, the
Society of Obstetricians and Gynaecologists of Canada
(SOGC) also remarked that there is no increased risk of
pre-eclampsia recurrence with longer inter-pregnancy
intervals. However there are some reports stating that
there is an increased recurrent risk with interpregnancy
intervals of less than 2 years or more than 10 years and
there are other or not providing recommendations on this
topic due to insufficient evidence [16–18].
We conducted a systematic review to explore the effect
of inter-pregnancy interval on the risk of recurrent pre-
eclampsia or eclampsia. This information is important to
improve shared decision making of health care providers
and women who had pre-eclampsia or eclampsia in the
previous pregnancy and plan to become pregnant again.
Methods
We followed the reporting recommendations of the
PRISMA statement and the Meta-analysis Of Observa-
tional Studies in Epidemiology group (MOOSE) [19, 20].
This review was registered in Prospero Centre for Re-
views and Dissemination, University of York: Systematic
review on inter-pregnancy interval and risk of recurrent
pre-eclampsia: CRD42015016682 [21].
Criteria for considering studies for this review
The studies included in this review required the following
criteria:
Type of studies: observational prospective or
retrospective cohort studies assessing the risk of
recurrent pre-eclampsia in the immediate subsequent
pregnancy according to different birth interval periods.
Type of participants: woman with a history of
pre-eclampsia or eclampsia in a singleton pregnancy.
We included studies with participants of any age, ethnic
group, parity, education and socio-economic status
fulfilling the previous criteria. Very specific groups of
women (e.g. women with systemic lupus, erythematosus
lupus, rheumatoid arthritis or diabetes) were not included.
Types of birth intervals: We included any type of birth
interval definition; e.g. inter-pregnancy interval defined
as the time between the date that the first pregnancy
ended and the date of the last menstrual period for the
second pregnancy; or inter-birth intervals defined as
the interval between the dates of two consecutive
births from two separate pregnancies.
Type of outcomes: our primary outcomes were
recurrent pre-eclampsia or eclampsia in the second
pregnancy irrespective of the severity, gestational age
at onset and definition. Any definition of pre-eclampsia
described by the authors was accepted.
In the studies included, the following outcomes were
also considered: (1) Incidence of hypertension in the sec-
ond pregnancy irrespective of severity, time of onset or
definition used and (2) Perinatal outcomes in the second
pregnancy: fetal and neonatal death, low birth weight
defined as weight at birth < 2.5 kg, and preterm birth
defined as gestational age < 37 weeks at delivery.
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Search strategy for identification of studies
The search strategy was developed with the assistance of a
librarian experienced in electronic search strategies for
systematic reviews from the Institute of Clinical Effective-
ness (IECS) and tested by a second expert in search strat-
egies from the World Health Organization (WHO). We
searched MEDLINE (1966 to Jul 7, 2015), EMBASE (1980
to Jul 7, 2015) and LILACS (1982 to Jul 7, 2015) using a
combination of medical subject headings, key word terms
and word variants for birth spacing and adverse outcomes.
The MEDLINE search strategy was translated into the
other databases using the appropriate controlled voc-
abulary as applicable. This review had no language rest-
rictions. Additional file 1 presents the search strategy
developed for this systematic review.
We searched systematic reviews and meta-analyses
from these databases to check their reference lists. We
checked the reference lists of primary studies selected
for full-text evaluation for additional potentially relevant
articles not identified by the electronic search. Authors
of relevant papers were contacted regarding any further
published or unpublished work. Authors of manuscripts
reporting incomplete information were contacted to pro-
vide the missing information. ISI Web of Science was
searched for papers citing studies included in the review.
Process of study identification, selection and data
extraction
Citations identified in the electronic databases were
imported in Early Reviewer Organizing Software (EROS)
and duplicates deleted [22]. EROS is a web-based soft-
ware designed specifically to perform the first stages of
systematic review by organizing the initial phases, dis-
tributing the workload, facilitating independent revision
of references and resolution of discrepancies, and in-
corporating quality assessment. Two investigators (GC
and APB) independently screened the titles and abstracts
to select potentially relevant citations for full text evalu-
ation. Discrepancies were resolved through discussion
and consensus. When citations were considered relevant
or when information in the title/abstract was insufficient
for decision on inclusion/exclusion criteria, the full text
was retrieved and evaluated.
A structured data-extraction form specifically designed
according to the information needs of this review was
created in Excel® to conduct data extraction. Two
reviewers (GC and APB) extracted the data from the
included citations independently. Data extraction from
the two reviewers was compared and discrepancies were
discussed until consensus was reached.
The information extracted from each study was the
following: Study identification information: author, pub-
lication year, country; study characteristics: design, data
collection period; type of women included; sample size:
number of women with pre-eclampsia in the first preg-
nancy; number of women who developed pre-eclampsia
in the second pregnancy; definitions of pre-eclampsia in
the two pregnancies and verification of diagnosis; and
definition of birth interval. Crude and adjusted RR or
OR, confidence intervals and adjustment factors were also
extracted. Information on change of partner, incidence of
hypertension and perinatal outcomes in the index
pregnancy were collected if data were available. When
required, data was extracted from the article’s graphs by
using Adobe Acrobat X1 pro. All imputed values and
numeric calculations were confirmed by a third person.
Risk of bias assessment
We assessed data quality in each included study using
The Newcastle-Ottawa Scale (NOS) for non-randomised
studies in meta-analyses [23]. Two reviewers (GC and
APB) independently assessed the quality of each in-
cluded study, discrepancies were discussed and if con-
sensus was not reached a third reviewer was consulted
(AC). The NOS scale for cohort studies assesses three
main domains. The first domain evaluates the selection
of the exposed, non-exposed cohorts and the ascertain-
ment of exposure. For the purpose of this review, we de-
fined a study as at low risk of bias if the exposed cohort
was derived from the general community, if the non-
exposed cohort belonged to the same group as the ex-
posed, and if there was documentation that the dates
used to calculate the inter-birth interval were extracted
from clinical records. On the other hand the study was
classified as at high risk of bias if the cohorts were de-
rived from a special group or there was no description
of how the interval was calculated. This domain also
evaluates the certitude that the cohorts did not have the
outcome at the beginning of the study. However for our
review all studies were at low risk of bias since the out-
come is pre-eclampsia in the second pregnancy and
women were included in the study on the basis of pre-
eclampsia in the first pregnancy.
The second domain assesses comparability of the co-
horts. We defined a study as at low risk of bias if the study
controlled for at least variables affecting pre-eclampsia
such as age or socioeconomic status and at high risk of
bias if results were not adjusted.
The third domain relates to the outcome and it evalu-
ates three aspects, outcome definition, time to develop
the outcome and adequate follow up. We classified the
study as at low risk of bias if there was a clear definition
of pre-eclampsia and eclampsia, or if authors reported
assessment on the basis of the ICD-10 codes. For the
second aspect we considered a study at low risk of bias
if the study allowed enough time for women to have a
second pregnancy and if the study allowed measurement
of pre-eclampsia in the postpartum period. Studies were
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also at low risk of bias if they had less than 20 % lost to
follow up or if the study reported that the subjects lost
to follow up were unlikely to introduce bias.
Strategy for analysis and data synthesis
The association between inter-pregnancy interval and
recurrent pre-eclampsia was calculated. Meta-analysis of
adjusted and unadjusted odds ratios (aOR or OR) with
95 % confidence intervals (CI) calculated using the generic
inverse variant method, was used to explore the association
between various interval lengths and adverse outcome [24].
We did not plan a reference inter-pregnancy interval a
priori; instead we used the intervals considered in the ori-
ginal studies. If inter-pregnancy intervals were defined dif-
ferently in the articles we planned to perform a meta-
regression analysis considering the exposure time [25]. If
the same data set was presented in multiple reports, that
providing the most information was considered. Where the
data available did not allow us to perform a meta-analysis
(e.g. incompatible birth intervals reported), we presented
data without further attempt to quantitatively synthesize it.
Sub-group analysis by stillbirth and change of partner
were performed. Interaction of other factors were assessed
using multivariate analysis.
Results
The search strategy retrieved a total of 1769 articles from
which 97 were selected for full text evaluation and finally
five articles [12–14, 26, 27] from four datasets were
included in the review (Fig. 1). Two of the five articles
reported results from the same dataset [13, 26]; however,
only the article reporting adjusted results was included
[26]. The main characteristics of the included studies are
shown in Table 1.
All studies were from high income countries, namely
Norway [12], Denmark [14], Sweden [26] and United States
[27]. All were retrospective cohorts of women with a single-
ton pregnancy diagnosed with pre-eclampsia or eclampsia
and a subsequent singleton pregnancy. No other exclusion
criteria in terms of other hypertension disorders of preg-
nancy (e.g. pre-existing hypertension) was mentioned in the
original articles. Sample sizes ranged from 8401 to 31,417.
Two studies reported data separately for pregnancies with
the same partner or different partner [12, 14]. Two studies
[14, 26] defined inter-pregnancy interval as the time be-
tween the birth of the first child and conception of the sec-
ond one; one study [12] defined the interval as the time
between deliveries calculated by subtracting the dates of
both births; and a further study [27] used the difference
Fig. 1 Study selection process for systematic review of the inter-pregnancy interval and risk of recurrent pre-eclampsia. PRISMA 2009
Flow Diagram
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Table 1 Main characteristics of included studies
Study Country Study design Sample size
(women with PE
in 1st pregnancy)
Definition of
inter-pregnancy
interval
Inter-pregnancy
interval studied
(years)
Elegibility criteria
in pregnancy 1
Outcome in
pregnancy 2
Definition of
outcome
Confounders used
in the adjustment
Basso 2001 Denmark Retrospective
cohort
8401 Interval between
birth of the first
child and
conception date
of the second one
≤1, 1–2, 2-3,
3–4, 4-5,
5–7, > 7.
Danish women with
PE that delivered at
the hospital, with a
28 weeks or more
single pregnancy
and whose children
were not given in
adoption who had
subsequently
given birth
PE or E ICD-9 and ICD-10 Maternal age in the
second pregnancy,
SES in the first
pregnancy and
change of SES
between the first
and second
pregnancies.
Mostello USA Retrospective
cohort
17,773 Interval between
birth of the first
child and conception
date of the second one
≤1, 1–2, 2-3,
3–4, 4-5, 5–6,
6-7, 7–8, > 8.
Women who delivered
their first 2 singleton
pregnancies at > 20
weeks gestation
PE or E PE = HT + proteinuria
or edema that is
generalized and overt
maternal age,
prepregnancy BMI,
smoking and SES
E = PE + convulsion,
coma or both
Trogstad Norway Retrospective
cohort
19,970 Time between the
dates of the two
deliveries
≤1, 1–5, 6-10,
11-15, > 15
All women with a first and
second singleton pregnancy
delivery after 16 weeks gestation
in Norway
PE or E BP > 140/90 after 20
week gestation
combined with
proteinuria ≥0.3 g/24 h
(≥ + 1 dipstick) on at
least two occasions.
ICD-8
maternal age in 2nd
pregnancy, new father,
year of second delivery.
Hernandez
Diaz
Sweden Retrospective
cohort
31,417 Difference between
dates of last menstrual
period
<2, 2-4, 4-6,
6-8, > 8
Women who had their first
delivery on or after 1 January
1987, with reproductive history
followed until the end of 2004.
PE or E ICD-9 and ICD-10 None
References: PE pre-eclampsia, HT hypertension, E Eclampsia, ICD International Classification of Disease, SES Socioeconomic status
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between the dates of the last menstrual periods of both
pregnancies.
Two of the four datasets [14, 26] were included in the
meta-analysis with a total of 26,174 singleton preg-
nancies. Basso et al. included a cohort of Danish women
with a singleton pregnancy of gestational age of 27 com-
pleted weeks or above, diagnosed with pre-eclampsia or
eclampsia and a subsequent pregnancy with information
on the partner in both births between 1980 and 1994.
However the OR for recurrent pre-eclampsia was re-
ported only for those women that did not change their
partner. The results were adjusted by maternal age and
socioeconomic status in the first pregnancy and change
of socioeconomic status between both pregnancies.
Mostello et al. included a retrospective cohort with con-
secutive singleton pregnancies of more than 20 weeks of
gestation diagnosed with pre-eclampsia or eclampsia and
a subsequent pregnancy between January 1989 and
December 2005. Results were adjusted by maternal age,
prepregnancy Body Mass Index (BMI), weight gain,
smoking, chronic disease, and socioeconomic status.
Four percent of this cohort had chronic hypertension.
Figures 2 and 3 present the forest plots of these two
studies with different comparisons. The aOR for recur-
rent pre-eclampsia with an inter-pregnancy interval of
less than 2 years compared to 2-4 years was 1.01 [95 %
CI 0.95 to 1.07] (N = 26,174) with low heterogeneity (P
= 0.72; I2 = 0 %). No differences were found when the
interval of less than 2 years was subdivided in two sub-
groups (less than 1 year or 1 to 2 years) and compared
to the 2-4 years interval (Fig. 2). The test for subgroup
differences shows a p value of 0.96 (I2 = 0 %) implying a
similar effect for subgroups. The aOR of recurrent pre-
eclampsia with an inter-pregnancy interval of more than
4 years compared to 2–4 years was 1.10 [95 % CI 1.02 to
1.19], with 26,174 women and low heterogeneity (P =
0.48; I2 = 0 %) (Fig. 3).
Two of the four datasets [12, 27] with a total of 51,387
singleton pregnancies were not included in the meta-
analysis. Trogstad et al. included a retrospective cohort of
pregnancies of more than 16 weeks of gestation with diag-
nosis of pre-eclampsia or eclampsia in the first pregnancy
and a subsequent singleton pregnancy between 1967 and
1998. This study was not included in the meta-analysis as
the reference interval used to calculate the OR was very
different from the other included studies (1 to 5 years)
[12]. The results were adjusted by maternal age, same
father and year of the second delivery and they are
reported in Table 2. The aOR of recurrent pre-eclampsia
for an inter-pregnancy interval of less than 1 year
compared to 1 to 5 years was 1.24 [95 % CI 0.83 to 1.85]
(N = 19,970). When longer intervals were compared with
intervals of 1 to 5 years, the aOR was 1.04 [95 % CI 0.93
to 1.16] for intervals of 6 to 10 years; 0.85 [95 % CI 0.61 to
1.19] for intervals of 11 to 15 years and 0.78 [95 % CI 0.48
to 1.27] for intervals longer than 15 years.
Hernandez-Díaz et al. included a cohort of pregnan-
cies from the first antenatal visit (usually at 8 to 12 week-
s’gestation) with diagnosis of pre-eclampsia or eclampsia
and a subsequent pregnancy between January 1987 and
December 2004 [27]. The study reports a 14.7 % risk of
recurrent pre-eclampsia. For those women with a history
of pre-eclampsia in the first pregnancy the risk of recur-
rence was 13.1 % if they became pregnant within 2 years
and 15.8 % if the next pregnancy was after 8 years or
later (Table 3). The authors did not report ORs or the
total number of women in each group, which would
have allowed their calculation. We contacted the authors
Fig. 2 Adjusted odds ratio of recurrent pre-eclampsia with inter-pregnancy interval below 2 years compared to 2–4 years (i.e. 0–1 and 1–2 years)
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but they no longer had access to the database to perform
the analysis required for inclusion in the meta-analysis.
None of the studies reported the incidence of hyper-
tension or perinatal outcomes in the second pregnancy
by inter-pregnancy intervals.
Change of partner and risk of pre-eclampsia or eclampsia
Two studies assessed the risk of recurrent pre-eclampsia
according to inter-pregnancy interval and change in
partner. Togstad et al. found similar results when the
analysis was performed separately for those pregnancies
with the same partner or when the partner changed be-
tween the first and the second pregnancy (Table 2). Baso
et al. in 2001 also reported very little effect of changing
partner on the risk of pre-eclampsia, although it seemed
to be protective in those intervals longer than 5 years
OR 0.56 (0.37-0.85). The OR of recurrent pre-eclampsia
associated with changing partner was 0.80 (CI 95 %
0.63-1.00) after adjustment for inter-pregnancy interval.
Risk of bias assessment
Quality assessment of included studies are described in
Figs. 4 and 5. For the first domain, all studies were classi-
fied as at low risk of bias as all were large retrospective co-
horts derived from the general community with the non-
exposed cohort belonging to the same group as the ex-
posed cohort. All of the studies included a description of
how the inter-birth or inter-pregnancy interval was calcu-
lated and how dates were extracted from clinical records.
Three studies [12–14] were classified as at low risk of
bias as results were adjusted by at least age of the
mother and socioeconomic status and one study [27]
was at high risk of bias as results were not adjusted.
All studies had a clear definition of pre-eclampsia or
eclampsia and three studies used the international classifi-
cation of disease to define the outcome. They all allowed
enough time for women to have a second pregnancy as
the cohort periods were between 14 and 30 years long.
Basso et al. and Hernandez Diaz et al. assessed pre-
eclampsia or eclampsia at discharge and were classified as
Table 2 Trostad 2001. Odds ratio of recurrent pre-eclampsia with inter-pregnancy intervals of less than 1 or 5 years or more
compared to 1–5 years. Results were adjusted by maternal age in 2nd pregnancy, new father, delivery year
Interval OR Low High Sub-group OR Low High Sub-group OR Low High
≤1 year 1.24 0.83 1.85 Same father 1.18 0.76 1.85 New father - - -
1–5 years Ref. Ref. Ref. Ref. Ref. Ref. Ref. Ref. Ref.
6–10 years 1.04 0.93 1.16 1.06 0.93 1.21 1.02 0.65 1.61
11–15 years 0.85 0.61 1.19 0.52 0.27 1.01 0.63 0.29 1.4
>15 years 0.78 0.48 1.27 0.73 0.28 1.91 0.52 0.19 1.41
Fig. 3 Adjusted odds ratio of recurrent pre-eclampsia with inter-pregnancy intervals greater than 4 years compared to 2–4 years
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at low risk of bias whereas Trogstad et al. evaluated pre-
eclampsia or eclampsia “at delivery ward within 1 week of
delivery” and Mostello et al. did not specify the timing of
evaluation, and were classified as at unknown risk. All
studies were also considered at low risk of bias due to loss
to follow up as the loss to follow up was unlikely to in-
troduce bias.
Discussion
Main Findings
This review identified five reports using four databases
which assessed the incidence of recurrent pre-eclampsia ac-
cording to inter-pregnancy interval. All studies reported
data from retrospective cohorts in high income countries.
Only two of the four datasets could be meta-analysed con-
cluding that when comparing inter-pregnancy interval
below 2 years with intervals of 2–4 years, there is no
significant increase in risk (aOR = 1.01 [95 % CI 0.95 to
1.07]). On the other hand, when comparing intervals of
more than 4 years with intervals of 2–4 years, we found a
significant small increase, aOR = 1.10 [95 % CI 1.02 to
1.19]. We found no heterogeneity between these estimates.
Change in partner between pregnancies has been
suggested to confound the relationship between inter-
pregnancy interval and pre-eclampsia, as change of part-
ner is often associated with longer interpregnancy inter-
vals [28, 29]. Since the incidence of pre-eclampsia is much
higher in first pregnancies, it has been suggested that the
decrease in risk in the second pregnancy is found only if
the father remains the same, the hypothesis being that the
maternal immune system builds tolerance to the paternal
antigens with repetitive exposure which is not the case if
the partner changes.
However the relationship may be more complex, in that
one needs to consider both the inherent propensity to
pre-eclampsia of each specific couple, and the modifying
effect of prolonged immunological exposure. The above
argument would hold when considering an unselected
population. In the case of a cohort selected on the basis of
previous pre-eclampsia, we would suggest that the
primary partnerships are selected as above average risk. In
this case, a change in partner may result in a partnership
with less inherent propensity to pre-eclampsia (on the
principle of regression to the mean). This may outweigh
the effect of less immunological exposure within the new
partnership, resulting in lower rather than increased risk
of recurrence. Therefore a change of partner, with a suffi-
cient period of vaginal exposure to seminal antigens may
decrease the likelihood of pre-eclampsia [30].
However, despite the hypothesis above, it has also been
argued that change in paternity is not a confounder but a
collider and thus controlling for this variable could be
inappropriate and produce spurious results [31]. In our
review, we found two studies which assessed the relation-
ship between inter-pregnancy interval and recurrent pre-
eclampsia controlling for change of partner but we did not
find a statistical nor clinical significant difference [12, 14].
Strengths and limitations
Strengths of this review include the broad search strategy
to capture the largest number of publications and the rela-
tively good quality of the original observational studies:
large retrospective population-based cohorts within a
period of 15 to 30 years. We tried to reduce bias by
screening and extracting the information in duplicate
using a data-extraction form specifically designed for this
review. Additionally, the meta-analysis included studies
with proper adjustment for confounding variables.
This review has several limitations. Only four datasets
studies were retrieved and all were from high income
countries. Exposure was defined differently in the included
Fig. 4 Methodological quality of included studies according to
Newcastle-Ottawa Scale criteria
Table 3 Hernández Díaz. Risk of recurrent pre-eclampsia in
second pregnancy by years since first pregnancy
Interval % Low High
< 2 years 13.13 12.26 14.00
2 to 4 years 14.87 14.20 15.54
4 to 6 years 16.62 15.01 18.23
6 to 8 years 15.96 13.18 18.75
> 8 years 15.85 12.39 19.32
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studies which restricted the analysis and interpretation.
Only two of the four datasets were included in the meta-
analysis as inter-pregnancy intervals were defined differ-
ently in one study and data was not adjusted in another
study. We planned to perform a meta-regression analysis
considering the exposure time, however we did not have a
sufficient number of studies for this type of analysis.
Furthermore, reported aOR were not adjusted for the
same confounders across the studies, nor did they include
all confounding factors known to play a role in the ass-
ociation between inter-pregnancy intervals and pre-
eclampsia or eclampsia. Three datasets were adjusted for
maternal age, one adjusted also for change of partner and
delivery year [12], a second one for socioeconomic status,
BMI and smoking [26] and a third one for socioeconomic
status [14].
In addition, other methodological limitations remain.
In the case of inter-birth intervals, it is important to
consider the confounding effect of complications in the
subsequent pregnancy leading to early delivery, which
creates bias towards a shorter inter-pregnancy interval.
For future research, we recommend that interpregnancy
interval (birth to commencement of the next pregnancy)
be used, as this interval is most useful to parents plan-
ning another pregnancy.
Also, the “short inter-pregnancy intervals” may have
been too broad and there was not enough data looking
at intervals of less than 1 year. Inter-pregnancy intervals
of less than 1 year would not be captured with the data
available for this meta-analysis. This is important since
some evidence has suggested that a period of 6 months
of unprotected sexual cohabitation may be enough to
decrease the risk of pre-eclampsia [32].
The analysis and interpretation of the data gathered by
this review would have been enhanced by including in-
formation on chronic or pre-existing hypertension, onset
of pre-eclampsia (early vs. late) as well as outcomes such
as stillbirth but unfortunately, there was not enough
information to explore subgroup analysis using these
variables [33].
Interpretation (in light of other evidence)
This is the first systematic review that assess the risk of
recurrent pre-eclampsia/eclampsia according to inter-
pregnancy or birth intervals. These results are in accord-
ance with those of a large cross-sectional study in Latin
America which assessed the relationship between inter-
pregnancy interval and ocurrence of pre-eclampsia and
other various maternal and perinatal outcomes. Without
considering the outcome of the previous pregnancy, the
above-mentioned study reported increased odds of pre-
eclampsia associated with longer inter-pregnancy inter-
vals [8]. Bearing in mind the scarcity of studies and the
limitations of the data available, the updated analysis in-
formation provided in this systematic review is import-
ant as it has been reported that intervals shorter than
2 years or longer than 10 years increased the risk of re-
current pre-eclampsia [16, 34]. In addition, even though
among the risk factors for recurrent pre-eclampsia,
inter-pregnancy interval may be regarded as a minor
contributor, it is nonetheless, together with weight con-
trol, a modifiable factor through which to intervene be-
fore conception.
Conclusion
Data from large population-based cohorts show evidence
that when compared to inter-pregnancy intervals of 2 to
4 years, shorter intervals are not associated with an in-
creased risk of recurrent pre-eclampsia. However, the
risk appears to increase in longer inter-pregnancy inter-
vals. The results of this review should be interpreted
with caution as the data available is limited and derives
from observational studies and thus subject to possible
confounding factors. Future research is requiered to
confirm our findings and to explore inter-pregnancy in-
tervals shorter than 1 year.
Fig. 5 Summary of methodological quality assessment of risk of bias and applicability concerns presented for each domain as percentages across
all included studies
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